• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

FOXA1通过抑制miR-100-5p和miR-125b-5p抑制鼻咽癌细胞的生长、迁移和侵袭。

FOXA1 Suppresses the Growth, Migration, and Invasion of Nasopharyngeal Carcinoma Cells through Repressing miR-100-5p and miR-125b-5p.

作者信息

Peng Qian, Zhang Liyang, Li Junjun, Wang Wei, Cai Jing, Ban Yuanyuan, Zhou Ying, Hu Meng, Mei Yan, Zeng Zhaoyang, Li Xiaoling, Xiong Wei, Li Guiyuan, Tan Yixin, Xiang Bo, Yi Mei

机构信息

Hunan Provincial Cancer Hospital and Cancer Hospital Affiliated to Xiangya Medical School, Central South University, Changsha 410013, Hunan, China.

The Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Cancer Research Institute and School of Basic Medical Sciences, Central South University, Changsha, 410078, Hunan, China.

出版信息

J Cancer. 2020 Feb 10;11(9):2485-2495. doi: 10.7150/jca.40709. eCollection 2020.

DOI:10.7150/jca.40709
PMID:32201519
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7066028/
Abstract

: Nasopharyngeal carcinoma (NPC) is a unique subtype of head and neck cancer, within highest incidence in South China and southeastern Asia but rare in other regions worldwide. FOXA1 is a pioneer factor implicated in various human malignancies. Downregulation of FOXA1 promotes NPC cells proliferation, invasiveness in vitro and tumorigenicity in vivo. However, it is remain elusive to determine whether microRNAs (miRNAs) regulated by FOXA1 contribute to NPC progression. : In this study, differentially expressed miRNAs and mRNAs induced by FOXA1 expression were determined by microarray. Integrative miRNA-mRNA regulatory networks mediated by FOXA1 in NPC were established. The expressions of differentially expressed miRNAs in NPC cells were measured by quantitative reverse-transcription PCR. Cell viability was determined by CCK-8 assays. Cell migration and invasiveness were measured by Transwell assays. The correlation between miRNAs and its target mRNAs was analyzed. : FOXA1 suppressed the expression of miR-100-5p and miR-125b-5p in NPC cells. Silencing either miR-100-5p or miR-125b-5p inhibited the malignant behaviors of NPC cells, whereas re-expression of miR-100-5p or miR-125b-5p restored the malignancy of NPC cells repressed by FOXA1. Mechanistically, miR-100-5p or miR-125b-5p suppressed RASGRP3 or FOXN3 expression respectively via direct binding to its 3'-UTR. Furthermore, we demonstrated that FOXA1 induced RASGRP3 or FOXN3 expression via inhibiting miR-100-5p or miR-125b-5p. Upregulation of RASGRP3 or FOXN3 contributed to inhibition of NPC by FOXA1. We also demonstrated that the mRNA levels of RASGRP3 and FOXN3 are positively correlated with FOXA1. : Our study provided evidence the first time that FOXA1 suppresses NPC cells via downregulation of miR-100-5p or miR-125b-5p.

摘要

鼻咽癌(NPC)是头颈癌的一种独特亚型,在中国南方和东南亚发病率最高,而在世界其他地区则较为罕见。FOXA1是一种与多种人类恶性肿瘤相关的先驱因子。FOXA1的下调促进了NPC细胞的增殖、体外侵袭性和体内致瘤性。然而,由FOXA1调控的微小RNA(miRNA)是否有助于NPC进展仍不清楚。

在本研究中,通过微阵列确定了由FOXA1表达诱导的差异表达miRNA和mRNA。建立了FOXA1在NPC中介导的综合miRNA-mRNA调控网络。通过定量逆转录PCR测量NPC细胞中差异表达miRNA的表达。通过CCK-8测定法测定细胞活力。通过Transwell测定法测量细胞迁移和侵袭性。分析了miRNA与其靶mRNA之间的相关性。

FOXA1抑制NPC细胞中miR-100-5p和miR-125b-5p的表达。沉默miR-100-5p或miR-125b-5p均可抑制NPC细胞的恶性行为,而重新表达miR-100-5p或miR-125b-5p可恢复被FOXA1抑制的NPC细胞的恶性程度。机制上,miR-100-5p或miR-125b-5p分别通过直接结合其3'-UTR抑制RASGRP3或FOXN3的表达。此外,我们证明FOXA1通过抑制miR-100-5p或miR-125b-5p诱导RASGRP3或FOXN3的表达。RASGRP3或FOXN3的上调有助于FOXA1对NPC的抑制作用。我们还证明RASGRP3和FOXN3的mRNA水平与FOXA1呈正相关。

我们的研究首次提供证据表明FOXA1通过下调miR-100-5p或miR-125b-5p抑制NPC细胞。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aba/7066028/c2abaf36e608/jcav11p2485g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aba/7066028/c309c2a94451/jcav11p2485g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aba/7066028/06f6b7a2ff1c/jcav11p2485g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aba/7066028/5f2d789b3237/jcav11p2485g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aba/7066028/d0072c6899b0/jcav11p2485g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aba/7066028/c5e4a0f8ce59/jcav11p2485g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aba/7066028/c1f21ddb11ce/jcav11p2485g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aba/7066028/c2abaf36e608/jcav11p2485g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aba/7066028/c309c2a94451/jcav11p2485g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aba/7066028/06f6b7a2ff1c/jcav11p2485g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aba/7066028/5f2d789b3237/jcav11p2485g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aba/7066028/d0072c6899b0/jcav11p2485g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aba/7066028/c5e4a0f8ce59/jcav11p2485g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aba/7066028/c1f21ddb11ce/jcav11p2485g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aba/7066028/c2abaf36e608/jcav11p2485g007.jpg

相似文献

1
FOXA1 Suppresses the Growth, Migration, and Invasion of Nasopharyngeal Carcinoma Cells through Repressing miR-100-5p and miR-125b-5p.FOXA1通过抑制miR-100-5p和miR-125b-5p抑制鼻咽癌细胞的生长、迁移和侵袭。
J Cancer. 2020 Feb 10;11(9):2485-2495. doi: 10.7150/jca.40709. eCollection 2020.
2
miR-574-5p Targets FOXN3 to Regulate the Invasion of Nasopharyngeal Carcinoma Cells via Wnt/β-Catenin Pathway.miR-574-5p 通过靶向 FOXN3 调控 Wnt/β-连环蛋白通路抑制鼻咽癌细胞的侵袭。
Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820971659. doi: 10.1177/1533033820971659.
3
MicroRNA-449b-5p suppresses cell proliferation, migration and invasion by targeting TPD52 in nasopharyngeal carcinoma.微小 RNA-449b-5p 通过靶向鼻咽癌中的 TPD52 抑制细胞增殖、迁移和侵袭。
J Biochem. 2019 Nov 1;166(5):433-440. doi: 10.1093/jb/mvz057.
4
Curcumin exerts inhibitory effects on undifferentiated nasopharyngeal carcinoma by inhibiting the expression of miR-125a-5p.姜黄素通过抑制 miR-125a-5p 的表达对未分化鼻咽癌发挥抑制作用。
Clin Sci (Lond). 2014 Nov;127(9):571-9. doi: 10.1042/CS20140010.
5
miR-125b-5p functions as a tumor suppressor gene partially by regulating HMGA2 in esophageal squamous cell carcinoma.miR-125b-5p在食管鳞状细胞癌中部分通过调控HMGA2发挥肿瘤抑制基因的作用。
PLoS One. 2017 Oct 2;12(10):e0185636. doi: 10.1371/journal.pone.0185636. eCollection 2017.
6
miR-371-5p suppresses the proliferative and migratory capacity of human nasopharyngeal carcinoma by targeting BCL2.微小RNA-371-5p通过靶向BCL2抑制人鼻咽癌的增殖和迁移能力。
Oncol Lett. 2018 Jun;15(6):9209-9215. doi: 10.3892/ol.2018.8481. Epub 2018 Apr 12.
7
MicroRNA-223-5p suppresses the progression of nasopharyngeal carcinoma by targeting DCLK1.微小RNA-223-5p通过靶向双皮质素样激酶1抑制鼻咽癌进展。
Oncol Lett. 2021 May;21(5):396. doi: 10.3892/ol.2021.12657. Epub 2021 Mar 18.
8
MicroRNA-30a-5p suppresses proliferation, invasion and tumor growth of hepatocellular cancer cells via targeting FOXA1.微小RNA-30a-5p通过靶向叉头框蛋白A1抑制肝癌细胞的增殖、侵袭和肿瘤生长。
Oncol Lett. 2017 Oct;14(4):5018-5026. doi: 10.3892/ol.2017.6745. Epub 2017 Aug 10.
9
H19/miR-675-5p Targeting SFN Enhances the Invasion and Metastasis of Nasalpharyngeal Cancer Cells.H19/miR-675-5p 靶向 SFN 增强鼻咽癌细胞的侵袭和转移。
Curr Mol Pharmacol. 2019;12(4):324-333. doi: 10.2174/1874467212666190719120446.
10
miR-491-5p suppresses cell growth and invasion by targeting Notch3 in nasopharyngeal carcinoma.miR-491-5p通过靶向Notch3抑制鼻咽癌细胞的生长和侵袭。
Oncol Rep. 2016 Jun;35(6):3541-7. doi: 10.3892/or.2016.4713. Epub 2016 Mar 29.

引用本文的文献

1
Targeting the FOXA1/BMI1 axis to overcome chemoresistance and suppress tumor progression in nasopharyngeal carcinoma.靶向FOXA1/BMI1轴以克服鼻咽癌的化疗耐药性并抑制肿瘤进展
Cell Death Discov. 2025 Jul 7;11(1):311. doi: 10.1038/s41420-025-02595-6.
2
Role and potential mechanisms of miR‑100 in different diseases (Review).miR-100在不同疾病中的作用及潜在机制(综述)
Oncol Rep. 2025 Aug;54(2). doi: 10.3892/or.2025.8924. Epub 2025 Jun 6.
3
FOXA2/miR-148a-3p/SMURF2 signaling feed-forward loop alleviates spinal cord ischemia-reperfusion injury-induced neuropathic pain by modulating microglia polarization in rats.

本文引用的文献

1
ΔNp63α is a super enhancer-enriched master factor controlling the basal-to-luminal differentiation transcriptional program and gene regulatory networks in nasopharyngeal carcinoma.ΔNp63α 是一个超级增强子富集的主调控因子,可控制鼻咽癌的基底到腔面分化转录程序和基因调控网络。
Carcinogenesis. 2020 Sep 24;41(9):1282-1293. doi: 10.1093/carcin/bgz203.
2
EGFR-PKM2 signaling promotes the metastatic potential of nasopharyngeal carcinoma through induction of FOSL1 and ANTXR2.EGFR-PKM2 信号通过诱导 FOSL1 和 ANTXR2 促进鼻咽癌的转移潜能。
Carcinogenesis. 2020 Jul 10;41(6):723-733. doi: 10.1093/carcin/bgz180.
3
Role of miRNAs in tumor and endothelial cell interactions during tumor progression.
FOXA2/miR-148a-3p/SMURF2信号前馈环通过调节大鼠小胶质细胞极化减轻脊髓缺血再灌注损伤诱导的神经性疼痛。
Front Immunol. 2025 May 13;16:1563377. doi: 10.3389/fimmu.2025.1563377. eCollection 2025.
4
MicroRNA-99 family in cancer: molecular mechanisms for clinical applications.癌症中的微小RNA-99家族:临床应用的分子机制
PeerJ. 2025 Mar 27;13:e19188. doi: 10.7717/peerj.19188. eCollection 2025.
5
miR‑100: A key tumor suppressor regulatory factor in human malignant tumors (Review).微小RNA-100:人类恶性肿瘤中的关键抑癌调节因子(综述)
Int J Mol Med. 2025 Apr;55(4). doi: 10.3892/ijmm.2025.5508. Epub 2025 Feb 28.
6
Foxa1 disruption enhances human cell integration in human-mouse interspecies chimeras.叉头框蛋白A1(Foxa1)缺失增强了人鼠异种嵌合体中人类细胞的整合。
Cell Tissue Res. 2025 Feb;399(2):231-245. doi: 10.1007/s00441-024-03941-3. Epub 2024 Dec 21.
7
FOXA1 enhances antitumor immunity via repressing interferon-induced PD-L1 expression in nasopharyngeal carcinoma.FOXA1 通过抑制鼻咽癌中干扰素诱导的 PD-L1 表达增强抗肿瘤免疫。
J Immunother Cancer. 2024 Nov 14;12(11):e010091. doi: 10.1136/jitc-2024-010091.
8
An ontology-based knowledge graph for representing interactions involving RNA molecules.基于本体的知识图谱,用于表示涉及 RNA 分子的相互作用。
Sci Data. 2024 Aug 22;11(1):906. doi: 10.1038/s41597-024-03673-7.
9
Identification of exosomal microRNAs and related hub genes associated with imatinib resistance in chronic myeloid leukemia.鉴定与慢性髓性白血病伊马替尼耐药相关的外泌体 microRNAs 和相关枢纽基因。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Dec;397(12):9701-9721. doi: 10.1007/s00210-024-03198-1. Epub 2024 Jun 25.
10
Super Enhancer Driven Hyaluronan Synthase 3 Promotes Malignant Progression of Nasopharyngeal Carcinoma.超级增强子驱动的透明质酸合酶3促进鼻咽癌的恶性进展。
J Cancer. 2023 Jun 12;14(10):1751-1762. doi: 10.7150/jca.83954. eCollection 2023.
miRNAs 在肿瘤进展过程中肿瘤细胞和内皮细胞相互作用中的作用。
Semin Cancer Biol. 2020 Feb;60:214-224. doi: 10.1016/j.semcancer.2019.07.024. Epub 2019 Aug 3.
4
MicroRNA expression patterns in oral squamous cell carcinoma: hsa-mir-99b-3p and hsa-mir-100-5p as novel prognostic markers for oral cancer.口腔鳞状细胞癌中的 microRNA 表达模式:hsa-mir-99b-3p 和 hsa-mir-100-5p 作为口腔癌的新型预后标志物。
Head Neck. 2019 Oct;41(10):3499-3515. doi: 10.1002/hed.25866. Epub 2019 Jul 29.
5
FOXA1 mutations alter pioneering activity, differentiation and prostate cancer phenotypes.FOXA1 突变改变了启动活性、分化和前列腺癌表型。
Nature. 2019 Jul;571(7765):408-412. doi: 10.1038/s41586-019-1318-9. Epub 2019 Jun 26.
6
Recent Advances in Understanding FOXN3 in Breast Cancer, and Other Malignancies.乳腺癌及其他恶性肿瘤中FOXN3研究的最新进展
Front Oncol. 2019 May 31;9:234. doi: 10.3389/fonc.2019.00234. eCollection 2019.
7
Nasopharyngeal carcinoma.鼻咽癌。
Lancet. 2019 Jul 6;394(10192):64-80. doi: 10.1016/S0140-6736(19)30956-0. Epub 2019 Jun 6.
8
miR-100-5p confers resistance to ALK tyrosine kinase inhibitors Crizotinib and Lorlatinib in EML4-ALK positive NSCLC.miR-100-5p 赋予 EML4-ALK 阳性 NSCLC 对 ALK 酪氨酸激酶抑制剂克唑替尼和洛拉替尼的耐药性。
Biochem Biophys Res Commun. 2019 Apr 2;511(2):260-265. doi: 10.1016/j.bbrc.2019.02.016. Epub 2019 Feb 18.
9
6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 and 4: A pair of valves for fine-tuning of glucose metabolism in human cancer.6-磷酸果糖-2-激酶/果糖-2,6-二磷酸酶 3 和 4:精细调节人类癌症中葡萄糖代谢的一对阀门。
Mol Metab. 2019 Feb;20:1-13. doi: 10.1016/j.molmet.2018.11.013. Epub 2018 Dec 5.
10
FOXA1 reprograms the TGF-β-stimulated transcriptional program from a metastasis promoter to a tumor suppressor in nasopharyngeal carcinoma.FOXA1 将 TGF-β 刺激的转录程序从鼻咽癌的转移促进因子重新编程为肿瘤抑制因子。
Cancer Lett. 2019 Feb 1;442:1-14. doi: 10.1016/j.canlet.2018.10.036. Epub 2018 Oct 28.